Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

Barclays logo

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

53.25p
   
  • Change Today:
    -0.25p
  • 52 Week High: 56.75
  • 52 Week Low: 43.75
  • Currency: UK Pounds
  • Shares Issued: 474.31m
  • Volume: 36,139
  • Market Cap: £252.57m
  • RiskGrade: 143

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 53.25p per share. In the last year Alliance Pharma's share price has ranged from 43.75p to 56.75p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 2.3% 2.4%
Div Cover 3.2 3.1
Op Mrgn 26.0% 23.9%
ROCE 87.7%  
Latest F'cast
P/E 13.8 12.8
PEG 1.5 1.7
Pr/Revenue 2.6 2.4
Pr/Book 1.4  
Latest F'cast
Revenue 101.7% 6.2%
PBT 46.4% 11.3%
EPS 9.4% 3.3%
DPS 10.0% 5.6%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 44.90 10.81 3.61p 8.8 n/a -0% 0.82p 2.6%
31-Dec-13 45.28 12.01 3.82p 10.6 1.8 +6% 0.91p 2.2%
31-Dec-14 43.54 10.16 3.36p 10.9 n/a -12% 1.00p 2.7%
31-Dec-15 48.34 15.18 3.52p 12.2 2.4 +5% 1.10p 2.6%
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 103.55 24.73 3.98p 13.4 4.0 +3% 1.28p 2.4%
31-Dec-18 109.95 27.43 4.52p 11.8 0.9 +14% 1.46p 2.8%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Interim Results 13-Sep-2017 07:00 RNS
Appointment of Joint Corporate Broker 06-Sep-2017 07:00 RNS
Notification of Interim Results 01-Aug-2017 07:00 RNS

Alliance Pharma ShareCast News

Alliance Pharma first-half sales up 8% 18-Jul-2017 ShareCast
Alliance Pharma wins £5m compensation from Sincl... 21-Mar-2017 ShareCast
Alliance Pharma to more than double revenue in 2... 23-Jan-2017 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 53.25p
Change Today -0.25p
% Change -0.47 %
52 Week High 56.75
52 Week Low 43.75
Volume 36,139
Shares Issued 474.31m
Market Cap £252.57m
RiskGrade 143

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43% below the market average43% below the market average43% below the market average43% below the market average43% below the market average
86.89% above the sector average86.89% above the sector average86.89% above the sector average86.89% above the sector average86.89% above the sector average
Price Trend
20.97% above the market average20.97% above the market average20.97% above the market average20.97% above the market average20.97% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income
2.2% below the market average2.2% below the market average2.2% below the market average2.2% below the market average2.2% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
75.81% above the market average75.81% above the market average75.81% above the market average75.81% above the market average75.81% above the market average
68.18% above the sector average68.18% above the sector average68.18% above the sector average68.18% above the sector average68.18% above the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 21-Dec-17 15-Jun-17
Paid 11-Jan-18 12-Jul-17
Amount 0.44p 0.81p

Trades for 20-Sep-2017

Time Volume / Share Price
16:00 3,222 @ 53.17p
15:53 4,527 @ 53.16p
15:46 3,200 @ 53.16p
15:10 7,753 @ 53.50p
15:09 7,461 @ 53.49p

Alliance Pharma Key Personnel

CEO John Dawson
Chair Andrew L Smith
Finance Director Andrew Franklin

Top of Page